Research programme: androgen receptor antagonists - Chugai

Drug Profile

Research programme: androgen receptor antagonists - Chugai

Alternative Names: CH 5137291; CH-4892789; CH-4892880; CH-4933468; CH4892280

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Chugai Pharmaceutical
  • Class Imidazolidines; Nitriles; Pyridines; Sulfonamides
  • Mechanism of Action Androgen receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Cancer in Japan (PO)
  • 19 Nov 2009 Pharmacodynamics and pharmacokinetics data from preclinical studies in Cancer presented at the 21st AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC-2009) ,
  • 16 Aug 2009 Pharmacodynamics data from a preclinical trial in cancer presented at the 238th American Chemical Society National Meeting (238th-ACS-2009)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top